American Journal of Kidney Diseases
Volume 52, Issue 5 , Pages 849-858 , November 2008

Prevalence and Associations of Coronary Artery Calcification in Patients With Stages 3 to 5 CKD Without Cardiovascular Disease

  • Jocelyn S. Garland, MD

      Affiliations

    • Department of Medicine, Division of Nephrology, Ontario, Canada
    • Queen's University Vascular Calcification Investigators, Ontario, Canada
    • Corresponding Author InformationAddress correspondence to Jocelyn S. Garland, MD, Rm 2043, Etherington Hall, Queen's University, Kingston, Ontario, Canada K7L 3N6
    • ,
  • Rachel M. Holden, MD

      Affiliations

    • Department of Medicine, Division of Nephrology, Ontario, Canada
    • Queen's University Vascular Calcification Investigators, Ontario, Canada
    • ,
  • Patti A. Groome, PhD

      Affiliations

    • Department of Community Health and Epidemiology, Queen's University, Kingston, Ontario, Canada
    • ,
  • Miu Lam, PhD

      Affiliations

    • Department of Community Health and Epidemiology, Queen's University, Kingston, Ontario, Canada
    • ,
  • Robert L. Nolan, MD

      Affiliations

    • Department of Radiology, Queen's University, Kingston, Ontario, Canada
    • ,
  • A. Ross Morton, MD

      Affiliations

    • Department of Medicine, Division of Nephrology, Ontario, Canada
    • Queen's University Vascular Calcification Investigators, Ontario, Canada
    • ,
  • William Pickett, PhD

      Affiliations

    • Department of Community Health and Epidemiology, Queen's University, Kingston, Ontario, Canada

Received 30 October 2007 ,Accepted 11 April 2008.

References 

  1. Matsuoka M, Iseki K, Tamashiro M, et al. Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis. Clin Exp Nephrol. 2004;8:54–58
  2. Block GA, Raggi P, Bellasi A, et al. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int. 2007;71:438–441
  3. Fox CS, Larson MG, Keyes MJ, et al. Kidney function is inversely associated with coronary artery calcification in men and women free of cardiovascular disease: The Framingham Heart Study. Kidney Int. 2004;66:2017–2021
  4. Kramer H, Toto R, Peshock R, et al. Association between chronic kidney disease and coronary artery calcification: The Dallas Heart Study. J Am Soc Nephrol. 2005;16:507–513
  5. Seyahi N, Kahveci A, Bolgayirli M, et al. Coronary artery calcification and chronically decreased GFR in living kidney donors. Am J Kidney Dis. 2007;49:143–152
  6. Russo D, Palmiero G, De Blasio AP, et al. Coronary artery calcification in patients with CRF not undergoing dialysis. Am J Kidney Dis. 2004;44:1024–1030
  7. Tomiyama C, Higa A, Dalboni MA, et al. The impact of traditional and non-traditional risk factors on coronary calcification in pre-dialysis patients. Nephrol Dial Transplant. 2006;21:2464–2471
  8. Weiner DE, Tighiouart H, Amin MG, et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: A pooled analysis of community-based studies. J Am Soc Nephrol. 2004;15:1307–1315
  9. Henry RM, Kostense PJ, Bos G, et al. Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study. Kidney Int. 2002;62:1402–1407
  10. Muntner P, He J, Hamm L. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol. 2002;13:745–753
  11. Muntner P, He J, Astor BC, et al. Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: Results from the Atherosclerosis Risk in Communities Study. J Am Soc Nephrol. 2005;16:529–538
  12. Shlipak MG, Fried LF, Cushman M, et al. Cardiovascular mortality risk in chronic kidney disease: Comparison of traditional and novel risk factors. JAMA. 2005;293:1737–1745
  13. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, classification, and stratification. Am J Kidney Dis. 2004;39(suppl 1):S1–S266
  14. Arnold JM, Liu P, Demers C, et al. Canadian Cardiovascular Society Canadian Cardiovascular Society Consensus Conference recommendations on heart failure 2006: Diagnosis and management. Can J Cardiol. 2006;22:23–45
  15. Hemingway H, Fitzpatrick NK, Gnani S, et al. Prospective validity of measuring angina severity with Canadian Cardiovascular Society class: The ACRE Study. Can J Cardiol. 2004;20:305–309
  16. Hemmelgarn BR, McAlister FA, Grover S, et al. Canadian Hypertension Education Program: The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension (Part 1—Blood pressure measurement, diagnosis and assessment of risk). Can J Cardiol. 2006;22:573–581
  17. McPherson R, Frohlich J, Fodor G, et al. Canadian Cardiovascular Society Canadian Cardiovascular Society position statement—Recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease. Can J Cardiol. 2006;22:913–927
  18. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee). Canadian Diabetes Association 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Can J Diabetes. 2003;27:S7–S9suppl 2
  19. Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837–1847
  20. Wexler L, Brundage B, Crouse J, et al. Coronary artery calcification: Pathophysiology, epidemiology, imaging methods, and clinical implications (A statement for health professionals from the American Heart Association Writing Group). Circulation. 1996;94:1175–1192
  21. Agatston AS, Janowitz WR, Hildner F. Quantification of coronary artery calcium using ultra fast computed tomography. J Am Coll Cardiol. 1990;15:827–832
  22. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation (Modification of Diet in Renal Disease Study Group). Ann Intern Med. 1999;130:461–470
  23. Levey AS, Coresh J, Greene T, et al. Chronic Kidney Disease Epidemiology Collaboration Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247–254
  24. Levey AS, Coresh J, Greene T, et al. Chronic Kidney Disease Epidemiology Collaboration Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem. 2007;53:766–772
  25. Rule AD, Larson TS, Bergstralh EJ, et al. Using serum creatinine to estimate glomerular filtration rate: Accuracy in good health and in chronic kidney disease. Ann Intern Med. 2004;141:929–937
  26. Froissart M, Rossert J, Jacquot C, et al. Predictive performance of the Modification of Diet in Renal Disease and Cockcroft-Gault equations for estimating renal function. J Am Soc Nephrol. 2005;16:763–773
  27. Blacher J, Guerin AP, Pannier B, et al. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension. 2001;38:938–942
  28. Block GA, Spiegel DM, Ehrlich J, et al. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int. 2005;68:1815–1824
  29. Goodman WG, Goldin J, Kuizon BD, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000;342:1478–1483
  30. Adragao T, Pires A, Lucas C, et al. A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients. Nephrol Dial Transplant. 2004;19:1480–1488
  31. Moe SM, O'Neill KD, Fineberg N, et al. Assessment of vascular calcification in ESRD patients using spiral CT. Nephrol Dial Transplant. 2003;18:1152–1158
  32. Braun J, Oldendorf M, Moshage W, et al. Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis. 1996;27:394–401
  33. Nitta K, Akiba T, Suzuki K, et al. Assessment of coronary artery calcification in hemodialysis patients using multi-detector spiral CT scan. Hypertens Res. 2004;27:527–533
  34. Weiner DE, Sayed T, Tighiouart H, et al. Cardiovascular outcomes and all-cause mortality: Exploring the interaction between CKD and cardiovascular disease. Am J Kidney Dis. 2006;48:392–401
  35. Kaysen GA. The microinflammatory state in uremia: Causes and potential consequences. J Am Soc Nephrol. 2001;12:1549–1557
  36. Block GA, Klassen PS, Lazarus JM, et al. Mineral metabolism, mortality and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004;15:2208–2218
  37. Young EW, Albert JM, Satayathum S, et al. Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and Practice Patterns Study. Kidney Int. 2005;67:1179–1187
  38. Slinin Y, Foley RN, Collins AJ. Calcium, phosphorus, parathyroid hormone and cardiovascular disease in hemodialysis patients: The USRDS Waves 1, 3 and 4 Study. J Am Soc Nephrol. 2005;16:1788–1793
  39. Arad Y, Spadaro LA, Goodman K, et al. Prediction of coronary events with electron beam computed tomography. J Am Coll Cardiol. 2000;36:1253–1260
  40. Shemesh J, Morag-Koren N, Goldbourt U, et al. Coronary calcium by spiral computed tomography predicts cardiovascular events in high-risk hypertensive patients. J Hypertens. 2004;22:605–610
  41. Weiner DE, Tighiouart H, Elsayed EF, et al. The Framingham predictive instrument in chronic kidney disease. J Am Coll Cardiol. 2007;17:217–224
  42. Goodman WG, London G, Amann K, et al. Vascular Calcification Work Group Vascular calcification in chronic kidney disease. Am J Kidney Dis. 2004;43:572–579
  43. London GM, Drueke TB. Atherosclerosis and arteriosclerosis in chronic renal failure. Kidney Int. 1997;51:1678–1695

 Originally published online as doi:10.1053/j.ajkd.2008.04.012 on June 19, 2008.

PII: S0272-6386(08)00825-1

doi: 10.1053/j.ajkd.2008.04.012

American Journal of Kidney Diseases
Volume 52, Issue 5 , Pages 849-858 , November 2008

Article Tools

* Image Usage & Resolution